Search by Drug Name or NDC

    NDC 55150-0344-01 DAPTOMYCIN 500 mg/10mL Details

    DAPTOMYCIN 500 mg/10mL

    DAPTOMYCIN is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is DAPTOMYCIN.

    Product Information

    NDC 55150-0344
    Product ID 55150-344_2106b93b-565c-43f9-9432-c5787c3aab5e
    Associated GPIs 16270030002140
    GCN Sequence Number 053190
    GCN Sequence Number Description daptomycin VIAL 500 MG INTRAVEN
    HIC3 W9B
    HIC3 Description CYCLIC LIPOPEPTIDES
    GCN 20569
    HICL Sequence Number 025673
    HICL Sequence Number Description DAPTOMYCIN
    Brand/Generic Generic
    Proprietary Name DAPTOMYCIN
    Proprietary Name Suffix n/a
    Non-Proprietary Name DAPTOMYCIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/10mL
    Substance Name DAPTOMYCIN
    Labeler Name Eugia US LLC
    Pharmaceutical Class Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213171
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0344-01 (55150034401)

    NDC Package Code 55150-344-01
    Billing NDC 55150034401
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-344-01) / 10 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2021-09-02
    NDC Exclude Flag N
    Pricing Information N/A